Conjugate Vaccine Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Conjugate Vaccine Market size is expected to grow at an annual average of 8% during 2022-2028. Conjugated vaccine refers to a vaccine in which bacterial capsular polysaccharides or antigens are attached or conjugated to proteins. This protein plays an important role in enhancing the immunogenicity of polysaccharides. This vaccine is primarily used to immunize infants and children against invasive diseases caused by the Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.

The following segmentation are covered in this report:

By Pathogen Type

• Bacterial Conjugate Vaccine
• Viral Conjugate Vaccine
• Combination (Viral and Bacterial) Conjugate Vaccine

By Disease Indication

• Pneumococcal
• Influenza
• Diphtheria Tetanus and Pertussis (DTP)
• Meningococcal
• Others

By Type

• Monovalent Conjugate Vaccines
• Multivalent Conjugate Vaccines

Company Profile

• Bio-Med
• Biological E. Limited
• Bharat Biotech
• GlaxoSmithKline plc
• Merck & Co
• Pfizer, Inc
• Serum institute of India Pvt. Ltd

Scope of the report

The research study analyses the Conjugate Vaccine Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Conjugate Vaccine Market Report

• What was the Conjugate Vaccine Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Conjugate Vaccine Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.